47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS market capWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
Sanofi ADS's market cap is 101.54B EUR: 2,407,843,014 shares outstanding at today's price of 47.01.
- Today
- 101.54B
- Average, 5 years
- 122.13B
- Low, 5 years
- 93.16B
- High, 5 years
- 149.03B
Market cap = price × shares outstanding = 47.01 × 2.41B = 101.54B
Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.
Market cap by year and by quarter
| Fiscal year | Period ending | Market cap |
|---|---|---|
| Today | 101.54B | |
| FY2025 | 31 Dec 2025 | 100.67B |
| FY2024 | 31 Dec 2024 | 116.57B |
| FY2023 | 31 Dec 2023 | 112.63B |
| FY2022 | 31 Dec 2022 | 113.24B |
| FY2021 | 31 Dec 2021 | 110.37B |
| FY2020 | 31 Dec 2020 | 99.68B |
| FY2019 | 31 Dec 2019 | 111.90B |
| FY2018 | 31 Dec 2018 | 94.41B |
| FY2017 | 31 Dec 2017 | 90.04B |
| FY2016 | 31 Dec 2016 | 98.82B |
| FY2015 | 31 Dec 2015 | 102.59B |
| FY2014 | 31 Dec 2014 | 99.18B |
| FY2013 | 31 Dec 2013 | 103.17B |
| FY2012 | 31 Dec 2012 | 94.75B |
| FY2011 | 31 Dec 2011 | 74.54B |
| FY2010 | 31 Dec 2010 | 62.84B |
| FY2009 | 31 Dec 2009 | 71.60B |
| FY2008 | 31 Dec 2008 | 60.31B |
| FY2007 | 31 Dec 2007 | 84.03B |
| FY2006 | 31 Dec 2006 | 94.23B |
| FY2005 | 31 Dec 2005 | 99.02B |
| FY2004 | 31 Dec 2004 | 53.80B |
| FY2003 | 31 Dec 2003 | 42.14B |
| FY2002 | 31 Dec 2002 | 42.16B |
| FY2001 | 31 Dec 2001 | 48.98B |
| FY2000 | 31 Dec 2000 | 46.21B |
| FY1999 | 31 Dec 1999 | 43.24B |
| Quarter | Period ending | Market cap |
|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 87.31B |
| Q2 FY2026 | 30 Jun 2026 | 89.36B |
| Q1 FY2026 | 31 Mar 2026 | 100.38B |
| Q4 FY2025 | 31 Dec 2025 | 100.67B |
| Q3 FY2025 | 30 Sept 2025 | 97.97B |
| Q2 FY2025 | 30 Jun 2025 | 101.16B |
| Q1 FY2025 | 31 Mar 2025 | 126.48B |
| Q4 FY2024 | 31 Dec 2024 | 116.77B |
| Q3 FY2024 | 30 Sept 2024 | 129.68B |
| Q2 FY2024 | 30 Jun 2024 | 115.60B |
| Q1 FY2024 | 31 Mar 2024 | 112.23B |
| Q4 FY2023 | 31 Dec 2023 | 112.80B |
| Q3 FY2023 | 30 Sept 2023 | 127.12B |
| Q2 FY2023 | 30 Jun 2023 | 123.56B |
| Q1 FY2023 | 31 Mar 2023 | 125.37B |
| Q4 FY2022 | 31 Dec 2022 | 113.43B |
| Q3 FY2022 | 30 Sept 2022 | 97.27B |
| Q2 FY2022 | 30 Jun 2022 | 119.41B |
| Q1 FY2022 | 31 Mar 2022 | 115.86B |
| Q4 FY2021 | 31 Dec 2021 | 110.58B |
| Q3 FY2021 | 30 Sept 2021 | 104.46B |
| Q2 FY2021 | 30 Jun 2021 | 111.14B |
| Q1 FY2021 | 31 Mar 2021 | 105.34B |
| Q4 FY2020 | 31 Dec 2020 | 99.68B |
| Q3 FY2020 | 30 Sept 2020 | 107.44B |
| Q2 FY2020 | 30 Jun 2020 | 113.93B |
| Q1 FY2020 | 31 Mar 2020 | 99.22B |
| Q4 FY2019 | 31 Dec 2019 | 112.19B |
| Q3 FY2019 | 30 Sept 2019 | 106.44B |
| Q2 FY2019 | 30 Jun 2019 | 96.39B |
| Q1 FY2019 | 31 Mar 2019 | 98.50B |
| Q4 FY2018 | 31 Dec 2018 | 94.30B |
| Q3 FY2018 | 30 Sept 2018 | 96.91B |
| Q2 FY2018 | 30 Jun 2018 | 85.40B |
| Q1 FY2018 | 31 Mar 2018 | 81.17B |
| Q4 FY2017 | 31 Dec 2017 | 89.76B |
| Q3 FY2017 | 30 Sept 2017 | 105.68B |
| Q2 FY2017 | 30 Jun 2017 | 105.44B |
| Q1 FY2017 | 31 Mar 2017 | 107.08B |
| Q4 FY2016 | 31 Dec 2016 | 98.53B |
| Q3 FY2016 | 30 Sept 2016 | 87.52B |
| Q2 FY2016 | 30 Jun 2016 | 96.98B |
| Q1 FY2016 | 31 Mar 2016 | 90.89B |
| Q4 FY2015 | 31 Dec 2015 | 102.49B |
| Q3 FY2015 | 30 Sept 2015 | 110.91B |
| Q2 FY2015 | 30 Jun 2015 | 116.05B |
| Q1 FY2015 | 31 Mar 2015 | 120.42B |
| Q4 FY2014 | 31 Dec 2014 | 99.18B |
| Q3 FY2014 | 30 Sept 2014 | 117.29B |
| Q2 FY2014 | 30 Jun 2014 | 102.04B |
| Q1 FY2014 | 31 Mar 2014 | 100.15B |
| Q4 FY2013 | 31 Dec 2013 | 103.02B |
| Q3 FY2013 | 30 Sept 2013 | 99.08B |
| Q2 FY2013 | 30 Jun 2013 | 104.80B |
| Q1 FY2013 | 31 Mar 2013 | 105.23B |
| Q4 FY2012 | 31 Dec 2012 | 94.85B |
| Q3 FY2012 | 30 Sept 2012 | 89.93B |
| Q2 FY2012 | 30 Jun 2012 | 78.55B |
| Q1 FY2012 | 31 Mar 2012 | 76.73B |
| Q4 FY2011 | 31 Dec 2011 | 75.04B |
| Q3 FY2011 | 30 Sept 2011 | 65.62B |
| Q2 FY2011 | 30 Jun 2011 | 73.27B |
| Q1 FY2011 | 31 Mar 2011 | 64.85B |
| Q4 FY2010 | 31 Dec 2010 | 62.90B |
| Q3 FY2010 | 30 Sept 2010 | 63.80B |
| Q2 FY2010 | 30 Jun 2010 | 64.26B |
| Q1 FY2010 | 31 Mar 2010 | 72.27B |
| Q4 FY2009 | 31 Dec 2009 | 71.62B |
| Q3 FY2009 | 30 Sept 2009 | 65.91B |
| Q2 FY2009 | 30 Jun 2009 | 54.87B |
| Q1 FY2009 | 31 Mar 2009 | 55.01B |
| Q4 FY2008 | 31 Dec 2008 | 60.20B |
| Q3 FY2008 | 30 Sept 2008 | 60.74B |
| Q2 FY2008 | 30 Jun 2008 | 55.39B |
| Q1 FY2008 | 31 Mar 2008 | 62.87B |
| Q4 FY2007 | 31 Dec 2007 | 83.21B |
| Q3 FY2007 | 30 Sept 2007 | 79.88B |
| Q2 FY2007 | 30 Jun 2007 | 80.31B |
| Q1 FY2007 | 31 Mar 2007 | 88.02B |
| Q4 FY2006 | 31 Dec 2006 | 94.39B |
| Q3 FY2006 | 30 Sept 2006 | 95.00B |
| Q2 FY2006 | 30 Jun 2006 | 102.34B |
| Q1 FY2006 | 31 Mar 2006 | 105.28B |
| Q4 FY2005 | 31 Dec 2005 | 99.31B |
| Q3 FY2005 | 30 Sept 2005 | 92.24B |
| Q2 FY2005 | 30 Jun 2005 | 90.42B |
| Q1 FY2005 | 31 Mar 2005 | 87.16B |
| Q4 FY2004 | 31 Dec 2004 | 47.47B |
| Q3 FY2004 | 30 Sept 2004 | 40.99B |
| Q2 FY2004 | 30 Jun 2004 | 35.82B |
| Q1 FY2004 | 31 Mar 2004 | 38.88B |
| Q4 FY2003 | 31 Dec 2003 | 43.04B |
| Q3 FY2003 | 30 Sept 2003 | 36.60B |
| Q2 FY2003 | 30 Jun 2003 | 35.80B |
| Q1 FY2003 | 31 Mar 2003 | 32.95B |
| Q4 FY2002 | 31 Dec 2002 | 41.48B |
| Q3 FY2002 | 30 Sept 2002 | 41.62B |
| Q2 FY2002 | 30 Jun 2002 | 43.95B |
See also:P/E ratio,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Sanofi ADS's market cap
Source: Financial Modeling Prep
